文献速递生殖医学

肥胖干预措施对男性生育力的影响:系统综述与Meta分析

The effect of obesity interventions on male fertility: a systematic review and meta-analysis.
PubMed 文献 · Hum Reprod Update · 2026-01-01

该系统综述与Meta分析纳入32项研究,评估生活方式、药物及减重手术对肥胖男性生育力的影响。生活方式干预后精子正常形态和前向运动力改善,减重手术未见临床显著的精液参数或DNA损伤改变,药物证据不足。

要点

  • 生活方式干预后精子正常形态平均差0.59%(95%CI 0.23-0.94),前向运动力平均差10.56%(95%CI 8.97-12.15)。
  • 减重手术前后随机效应Meta分析未发现临床显著的精液参数或DNA损伤改变。
  • 所有干预对受孕率和辅助生殖结局的评估有限,证据确定性低。

核心结论

  • 减重干预与男性生育力的数据主要限于观察性研究且以精液质量为替代终点,证据确定性低。
  • 生活方式干预后精液质量改善提示优化营养和体育活动的潜在获益,而减重手术后改变有限提示肥胖相关精子功能障碍不随体重下降呈剂量依赖性缓解或快速减重存在负面影响。
  • 已识别的显著知识空白包括随机试验有限、受孕结局评估不足及GLP-1激动剂效果评估有限。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Web of Science、Embase、Cochrane中央对照试验注册库和Scopus自建库至2024年12月发表的英文文献。
  • 纳入18-50岁接受具明确减重获益的肥胖干预且干预前后重复评估生育能力(精液分析、受孕率、辅助生殖结局)的男性研究。
  • 共纳入32项研究,其中1项同时评估生活方式干预和药物治疗;减重手术评估18项研究,药物(二甲双胍和利拉鲁肽)评估5项研究,生活方式干预评估10项研究。
  • 当同一干预方式有2项及以上研究以适合Meta分析的方式评估同一结局时进行Meta分析;当有5项及以上合适研究时进行考虑减重幅度的Meta回归。
  • 对不适合Meta分析的研究进行叙述性综述。

主要发现

  • 随机对照试验的固定效应和随机效应Meta分析未发现任何干预下对照组与干预组之间精子参数的差异,但样本量小限制了解读。
  • 减重手术前后结局的随机效应Meta分析未发现临床显著的精液参数或DNA损伤改变。
  • 生活方式干预的固定效应Meta分析发现精子正常形态改善(平均差=0.59%,95%CI=[0.23, 0.94])和前向运动力改善(10.56%[8.97, 12.15])。
  • 药物治疗方面数据不足以就这些药物对生育结局的影响得出明确结论。
  • 所有干预方式对受孕率和辅助生殖的评估均有限。

关键数值与推荐

  • 生活方式干预后精子正常形态平均差=0.59%(95%CI=[0.23, 0.94])。
  • 生活方式干预后精子前向运动力平均差=10.56%(95%CI=[8.97, 12.15])。
  • 随机对照试验Meta分析中对照组与干预组精子参数无差异。
  • 减重手术前后Meta分析中精液参数或DNA损伤无临床显著改变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 几乎所有情况下肥胖干预对精液质量的影响均作为生育能力的替代指标进行检查,且证据确定性低。
  • 随机对照试验样本量小限制了解读。
  • 所有干预方式对受孕率和辅助生殖的评估均有限。
  • 药物治疗方面数据不足以得出明确结论。
  • 已识别的知识空白包括随机试验有限、受孕结局评估不足及GLP-1激动剂效果评估有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obesity is a prevalent modifiable cause of male factor infertility. Preconception guidelines recommend men maintain a healthy weight; however, they provide limited guidance regarding methods or volume of weight loss for men with obesity. First-line interventions for weight loss involve lifestyle optimization (healthy diet and exercise), followed by pharmacotherapy or bariatric surgery in severe cases. Each modality has differing weight loss potential and complications for which the reproductive implications are currently unclear. OBJECTIVE AND RATIONALE: To synthesize the available evidence regarding the reproductive effects of obesity interventions in men with obesity. Where possible, to evaluate whether the observed effects depend on the magnitude of weight loss. SEARCH METHODS: Searches for articles published in English was performed using PubMed, Web of Science, Embase, Cochrane Central Register of Controlled Trials and Scopus from inception until December 2024, using prespecified keywords pertaining to four categories: male, overweight/obesity, weight loss (bariatric surgery, nutrition, diet, lifestyle, exercise, pharmacotherapy) and fertility (conception, assisted reproduction, sperm, semen). Studies of reproductive-aged men (18-50 years) who underwent an obesity intervention with established weight loss benefits and undertook repeated assessment of reproduction capacity (semen analysis, conception rates, assisted reproduction outcomes) before and after the intervention were included. Meta-analysis was performed when two or more studies of the same modality assessed an outcome measure in a manner suitable for meta-analysis. A meta-regression considering weight loss achieved was performed when five or more suitable studies were available. Narrative review of studies not suitable for meta-analysis occurred. OUTCOMES: 32 studies were included in the analysis, with one study assessing both lifestyle interventions and pharmacotherapy. Assessment of conception rates and assisted reproduction was limited across all modalities. In almost all cases, the effect of obesity interventions on semen quality was examined as a surrogate for reproductive capacity and the certainty of evidence was low. Bariatric surgery was assessed in 18 studies, including 12 quasi-experimental studies, one randomized controlled trial, one case series and four case reports. Fixed- and random-effects meta-analysis of randomized controlled trials identified no differences in sperm parameters between control and intervention arms across any intervention, although small sample size limits interpretability. Random-effects meta-analyses of pre-post outcomes identified no clinically significant semen parameters or DNA damage changes following bariatric surgery. Pharmacotherapy (metformin and liraglutide) was assessed in five studies, including four quasi-experimental studies and one case report. There were insufficient data to draw clear conclusions regarding the impact of these agents on fertility outcomes. Lifestyle interventions were assessed in 10 studies, including five quasi-experimental studies and five randomized controlled trials. Fixed-effect meta-analysis identified improvements in sperm normal morphology (Mean difference = 0.59%, 95% Confidence interval = [0.23, 0.94]), and progressive motility (10.56% [8.97, 12.15]) following a lifestyle intervention. WIDER IMPLICATIONS: Data regarding weight loss interventions and male fertility is limited primarily to observational studies examining semen quality. Improvements in semen quality following lifestyle interventions suggest a potential benefit of optimizing nutrition and physical activity, whereas a limited change with bariatric surgery indicates obesity-associated sperm dysfunction does not resolve in a dose-dependent manner with weight loss and/or negative effects of rapid weight loss exist. Substantial knowledge gaps were identified, including limited randomized trials, inadequate examination of conception outcomes and limited assessment of GLP-1 agonist effects. REGISTRATION NUMBER: CRD 42022349665.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Peel A, Lyons H, Tully CA, et al. The effect of obesity interventions on male fertility: a systematic review and meta-analysis. Hum Reprod Update. 2026. PMID: 41065428. doi:10.1093/humupd/dmaf025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。